Display options
Share it on

Dig Dis Sci. 1996 Feb;41(2):250-5. doi: 10.1007/BF02093812.

Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.

Digestive diseases and sciences

U Baumgartner, J Schölmerich, M Sellinger, M Reinhardt, G Ruf, E H Farthmann

Affiliations

  1. Department of Surgery, University of Freiburg, Germany.

PMID: 8601366 DOI: 10.1007/BF02093812

Abstract

The coinfusion of tauroursodeoxycholate (TUDC) prevents taurolithocholate (TLC) -induced cholestasis. 23-Methyl-ursodeoxycholate (MUDC) is a side-chain derivative of ursodeoxycholate (UDC). If conjugation with taurine is important for the protective effect of UDC, the MUDC may not be as able as TUDC to prevent TLC-induced cholestasis since it is poorly amidated by the liver. To answer this question, isolated livers of adult Sprague-Dawley rats were coinfused with MUDC (UDC, TUDC) and TLC. After 15 min, inflow rates of the bile acids were doubled. In further experiments taurine in excess was added to the coinfused bile acids. The uptake of bile acids was >90% in all groups, irrespective of whether they were perfused alone or in combination. Single perfusion of TLC caused a rapid decrease in bile flow. UDC and MUDC were hypercholeretic; TUDC moderately choleretic. During coinfusion experiments, TUDC not only completely abolished cholestasis but in addition increased bile flow and biliary bile acid secretion. UDC did prevent TLC cholestasis at the lower inflow rates. At high inflow rates, bile flow decreased significantly. Addition of taurine to this bile acid combination did not significantly improve the anticholestatic effect of UDC. At low and high infusion rates of MUDC, cholestasis induced by TLC was reduced very little. Cumulative bile flow over 30 min fell by approximately 70% as compared to that of singly perfused MUDC. Addition of taurine to the coinfused MUDC/TLC slightly, but less significantly, improved the anticholestatic effect of MUDC. Since MUDC is by far less protective than UDC (and TUDC) despite similar physiochemical properties, it is concluded that taurine conjugation of UDC seems to be a prerequisite to prevent TLC-induced cholestasis. The results imply that treatment of cholestatic liver diseases with taurine-conjugated UDC might be more appropriate than with unconjugated UDC in cases where taurine conjugation is defective or where taurine depletion has occurred.

References

  1. J Lipid Res. 1977 May;18(3):404-7 - PubMed
  2. Am J Physiol. 1986 Dec;251(6 Pt 1):G852-8 - PubMed
  3. Gastroenterology. 1980 Jul;79(1):82-9 - PubMed
  4. J Hepatol. 1989 Jan;8(1):7-12 - PubMed
  5. Am J Physiol. 1984 Dec;247(6 Pt 1):G736-48 - PubMed
  6. Dig Dis Sci. 1992 May;37(5):791-8 - PubMed
  7. Lab Invest. 1987 Jun;56(6):576-82 - PubMed
  8. Gastroenterology. 1993 Jun;104(6):1736-44 - PubMed
  9. Methods Enzymol. 1986;133:215-29 - PubMed
  10. Proc Soc Exp Biol Med. 1985 Jan;178(1):60-7 - PubMed
  11. Res Exp Med (Berl). 1990;190(2):121-9 - PubMed
  12. J Clin Invest. 1993 Dec;92(6):2984-93 - PubMed
  13. Gastroenterology. 1989 Nov;97(5):1268-74 - PubMed
  14. Am J Physiol. 1984 Feb;246(2 Pt 1):G166-72 - PubMed
  15. Liver. 1993 Oct;13(5):262-9 - PubMed
  16. Hepatology. 1988 Nov-Dec;8(6):1571-6 - PubMed
  17. Hepatology. 1990 Nov;12(5):1216-21 - PubMed
  18. Am J Physiol. 1984 Jan;246(1 Pt 1):G67-71 - PubMed
  19. Biochem J. 1983 Oct 15;216(1):107-11 - PubMed
  20. Biochim Biophys Acta. 1992 Apr 23;1125(2):142-9 - PubMed
  21. Lancet. 1989 Apr 22;1(8643):898-9 - PubMed
  22. J Lipid Res. 1984 Dec 15;25(13):1477-89 - PubMed
  23. J Hepatol. 1990 May;10(3):280-3 - PubMed
  24. Gastroenterology. 1986 Apr;90(4):837-52 - PubMed
  25. Am J Physiol. 1986 Oct;251(4 Pt 1):G431-5 - PubMed
  26. J Lipid Res. 1987 Dec;28(12 ):1384-97 - PubMed
  27. Gastroenterology. 1991 Jan;100(1):203-11 - PubMed
  28. Life Sci. 1981 Jul 20;29(3):269-75 - PubMed
  29. J Hepatol. 1993 Nov;19(3):367-76 - PubMed

Substances

MeSH terms

Publication Types